118 Results

People

  1. Motzer
    Motzer
  2. Abou-Alfa
    Abou-Alfa
  3. Drilon
    Drilon
  4. Morris
    Morris
  5. Scher
    Scher
  6. Ladanyi
    Ladanyi
  7. Voss
    Voss
  8. Carlo
    Carlo
  9. Feldman
    Feldman
  10. Kotecha
    Kotecha

Groups

  1. Department of Medicine (105)
  2. Solid Tumor Oncology Division (97)
  3. Genitourinary Oncology Service (55)
  4. Thoracic Oncology (19)
  5. Gastrointestinal Oncology Service (18)
  6. GSK Faculty (14)
  7. Sloan Kettering Institute Postdocs (14)
  8. Radiology, Department of (13)
  9. Weinberg Fellows (12)
  10. Department of Pathology and Laboratory Medicine (11)
  1. "cabozantinib"
Formats
  1. Journal Article (88)
  2. Review (18)
  3. Editorial (4)
  4. Research Letter (3)
  5. Correspondence (2)
  6. Meeting Abstract (2)
  7. Guidelines (1)
Groups
  1. Department of Medicine (105)
  2. Solid Tumor Oncology Division (97)
  3. Genitourinary Oncology Service (55)
  4. Thoracic Oncology (19)
  5. Gastrointestinal Oncology Service (18)
  6. GSK Faculty (14)

More Groups

People
  1. Robert Motzer (25)
  2. Alexander Drilon (16)
  3. Ghassan Abou-Alfa (16)
  4. Michael Morris (11)
  5. Howard Scher (8)
  6. Marc Ladanyi (7)

More People

Years
  1. 2025 (8)
  2. 2024 (11)
  3. 2023 (12)
  4. 2022 (15)
  5. 2021 (7)
  6. 2020 (18)

More Years

Publications
  1. European Urology (8)
  2. Clinical Cancer Research (6)
  3. European Journal of Cancer (6)
  4. New England Journal of Medicine (6)
  5. Journal of Thoracic Oncology (5)
  6. Current Treatment Options in Oncology (4)

More Publications

Publishers
  1. Elsevier Inc. (23)
  2. Elsevier Science, Inc. (14)
  3. American Association for Cancer Research (8)
  4. Oxford University Press (7)
  5. Massachusetts Medical Society (6)
  6. Springer (5)

More Publishers

Results (118)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Real-world treatment patterns and clinical outcomes for metastatic renal cell carcinoma in the current treatment era
    Journal Article

    Shah, N. J.; Sura, S. D.; Shinde, R.; Shi, J.; Singhal, P. K.; Robert, N. J.; Vogelzang, N. J.; Perini, R. F.; Motzer, R. J.
    European Urology Open Science (2023)

    Fulltext@MSK | Save
  • Personalizing first-line management of metastatic renal cell carcinoma: Leveraging current and novel therapeutic options
    Review

    Fitzgerald, K. N.; Lee, C. H.
    Journal of the National Comprehensive Cancer Network (2022)

    Fulltext@MSK | Save
  • Efficacy of cabozantinib in metastatic MiT family translocation renal cell carcinomas
    Journal Article

    Thouvenin, J.; Alhalabi, O.; Carlo, M.; Carril-Ajuria, L.; Hirsch, L.; Martinez-Chanza, N.; Negrier, S.; Campedel, L.; Martini, D.; Borchiellini, D.; more...
    The Oncologist (2022)

    Fulltext@MSK | Save
  • Nivolumab plus ipilimumab plus cabozantinib triplet combination for patients with previously untreated advanced renal cell carcinoma: Results from a discontinued arm of the phase III CheckMate 9ER trial
    Journal Article

    Apolo, A. B.; Powles, T.; Escudier, B.; Burotto, M.; Zhang, J.; Simsek, B.; Scheffold, C.; Motzer, R. J.; Choueiri, T. K.
    European Journal of Cancer (2022)

    Fulltext@MSK | Save
  • LIBRETTO-531: A phase III study of selpercatinib in multikinase inhibitor-naïve RET-mutant medullary thyroid cancer
    Review

    Wirth, L. J.; Brose, M. S.; Elisei, R.; Capdevila, J.; Hoff, A. O.; Hu, M. I.; Tahara, M.; Robinson, B.; Gao, M.; Xia, M.; more...
    Future Oncology (2022)

    Fulltext@MSK | Save
  • Predictive biomarkers of overall survival in patients with metastatic renal cell carcinoma treated with IFNα ± bevacizumab: Results from CALGB 90206 (alliance)
    Journal Article

    Nixon, A. B.; Halabi, S.; Liu, Y.; Starr, M. D.; Brady, J. C.; Shterev, I.; Luo, B.; Hurwitz, H. I.; Febbo, P. G.; Rini, B. I.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Brief Report: Chylothorax and chylous ascites during RET tyrosine kinase inhibitor therapy
    Journal Article

    Kalchiem-Dekel, O.; Falcon, C. J.; Bestvina, C. M.; Liu, D.; Kaplanis, L. A.; Wilhelm, C.; Eichholz, J.; Harada, G.; Wirth, L. J.; Digumarthy, S. R.; more...
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save
  • An interdisciplinary consensus on the management of brain metastases in patients with renal cell carcinoma
    Review

    Hasanov, E.; Yeboa, D. N.; Tucker, M. D.; Swanson, T. A.; Beckham, T. H.; Rini, B.; Ene, C. I.; Hasanov, M.; Derks, S.; Smits, M.; more...
    CA - A Cancer Journal for Clinicians (2022)

    Fulltext@MSK | Save
  • An exploratory analysis of the “Was it worth it?” questionnaire as a novel metric to capture patient perceptions of cancer treatment
    Journal Article

    Thanarajasingam, G.; Basch, E.; Mead-Harvey, C.; Bennett, A. V.; Mazza, G. L.; Schwab, G.; Roydhouse, J.; Rogak, L. J.; Dueck, A. C.
    Value in Health (2022)

    Fulltext@MSK | Save
  • Nivolumab plus cabozantinib versus sunitinib in first-line treatment for advanced renal cell carcinoma (CheckMate 9ER): Long-term follow-up results from an open-label, randomised, phase 3 trial
    Journal Article

    Motzer, R. J.; Powles, T.; Burotto, M.; Escudier, B.; Bourlon, M. T.; Shah, A. Y.; Suárez, C.; Hamzaj, A.; Porta, C.; Hocking, C. M.; more...
    Lancet Oncology (2022)

    Fulltext@MSK | Save